In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.
D000606:Amino Sugars / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D001769:Blood; D002228:Carbenicillin / Q000494:pharmacology; D004357:Drug Synergism; D006027:Glycosides / Q000494:pharmacology; D006801:Humans; D007106:Immune Sera; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011485:Protein Binding; D011549:Pseudomonas / Q000187:drug effects*; D012965:Sodium Chloride / Q000494:pharmacology
D000606:Amino Sugars; D000900:Anti-Bacterial Agents; D006027:Glycosides; D007106:Immune Sera; D010406:Penicillins; D012965:Sodium Chloride; D002228:Carbenicillin